Correlation Between Zaptec AS and XSpray Pharma
Can any of the company-specific risk be diversified away by investing in both Zaptec AS and XSpray Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zaptec AS and XSpray Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zaptec AS and XSpray Pharma AB, you can compare the effects of market volatilities on Zaptec AS and XSpray Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zaptec AS with a short position of XSpray Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zaptec AS and XSpray Pharma.
Diversification Opportunities for Zaptec AS and XSpray Pharma
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Zaptec and XSpray is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Zaptec AS and XSpray Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XSpray Pharma AB and Zaptec AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zaptec AS are associated (or correlated) with XSpray Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XSpray Pharma AB has no effect on the direction of Zaptec AS i.e., Zaptec AS and XSpray Pharma go up and down completely randomly.
Pair Corralation between Zaptec AS and XSpray Pharma
Assuming the 90 days trading horizon Zaptec AS is expected to under-perform the XSpray Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Zaptec AS is 1.17 times less risky than XSpray Pharma. The stock trades about -0.03 of its potential returns per unit of risk. The XSpray Pharma AB is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 5,530 in XSpray Pharma AB on September 12, 2024 and sell it today you would lose (1,000.00) from holding XSpray Pharma AB or give up 18.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Zaptec AS vs. XSpray Pharma AB
Performance |
| Timeline |
| Zaptec AS |
| XSpray Pharma AB |
Zaptec AS and XSpray Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zaptec AS and XSpray Pharma
The main advantage of trading using opposite Zaptec AS and XSpray Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zaptec AS position performs unexpectedly, XSpray Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XSpray Pharma will offset losses from the drop in XSpray Pharma's long position.The idea behind Zaptec AS and XSpray Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| XSpray Pharma vs. Bavarian Nordic | XSpray Pharma vs. BioPorto | XSpray Pharma vs. Zaptec AS | XSpray Pharma vs. cBrain AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |